IRIS
PESCE, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.874
Totale 5.874
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.874
Totale 5.874
Salva come PNG Salva come JPEG
Città #
Genova 3.908
Genoa 667
Rapallo 641
Vado Ligure 633
Bordighera 25
Totale 5.874
Salva come PNG Salva come JPEG
Nome #
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 169
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 164
NK/DC crosstalk in anti-viral response. 161
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 157
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 155
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 147
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 145
NK cells and their receptors during viral infections. 144
Bridging innate NK cell Functions with Adaptive Immunity. 141
Features of Memory-Like and PD-1+ Human NK Cell Subsets 138
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 133
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 133
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 132
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 131
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 125
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 123
Harnessing NK Cells for Cancer Treatment 122
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 118
Human NK cell response to pathogens 117
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 116
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 115
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 114
TLR/NCR/KIR: Which One to Use and When? 113
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 109
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 105
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 101
The NK/DC complot 96
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 93
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 92
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 92
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 92
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 90
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 87
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 87
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 84
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 84
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 82
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 80
NK cells to cure cancer 79
The innate immune cross talk between NK cells and eosinophils is regulated by the interaction of Natural Cytotoxicity Receptors with eosinophil surface ligands 78
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 75
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 74
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 68
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry 68
New Insights into Endometrial Cancer 68
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 66
null 66
The NK/DC complot 63
Harnessing Immune Response in Acute Myeloid Leukemia 62
NK Cell-Based Immunotherapy in Colorectal Cancer 61
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 60
Female Malignancies and Immunotherapy: What's New? 60
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 57
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 55
Regolazione recettore mediata dell’Homing delle cellule NK umane 54
Neutrophilic priming of NK cells enhance the response to ensuing IL-12 stimulation 51
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts 45
The PD-1 immune checkpoint on human NK cells in normal and pathological condition 38
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 37
A CRISPR approach to manipulating NK cell receptor ligand expression in leukemic cells 35
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 30
Relevant role for PD-1 immune checkpoint expressed on NK cells derived from ovarian cancer patients 29
Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art 29
Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1 27
Natural killer cell impairment in ovarian clear cell carcinoma 27
NK/DC crosstalk in anti-viral response 27
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers 25
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 21
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans 18
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 15
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity 13
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells 12
Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors 7
Totale 6.087
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.593
article - articoli 16.825
book - libri 0
conference - conferenze 3.195
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 573
Totale 41.186
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020933 0 0 0 0 0 0 225 113 159 235 162 39
2020/2021681 47 35 40 37 24 153 23 45 63 101 51 62
2021/2022720 24 36 60 48 48 53 47 171 58 68 35 72
2022/2023777 86 68 6 74 107 120 2 66 143 8 84 13
2023/2024532 27 70 14 65 36 52 39 72 27 27 40 63
2024/2025692 36 100 65 117 212 153 9 0 0 0 0 0
Totale 6.087